Home » FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
Rogue online pharmacies looking to cash in on drugs in short supply are peddling counterfeit versions of Teva’s attention-deficit/hyperactivity disorder drug Adderall, the FDA warns. Teva discovered the sales of Adderall (dextroamphetamine/amphetamine) 30-mg tablets containing the wrong active ingredients when patients alerted the company to errors in product packaging, Teva spokeswoman Denise Bradley said.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May